These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 840136)

  • 41. Pharmacokinetics of pentoxifylline during concomitant theophylline administration to rats.
    Rocci ML; Luke DR; Saccar CL
    Pharm Res; 1987 Oct; 4(5):433-5. PubMed ID: 3508555
    [No Abstract]   [Full Text] [Related]  

  • 42. Absorption, distribution, excretion, and metabolism of 1-(5-oxohexyl) theobromine (BL 191) in rats.
    Fujimoto K; Yoshida S; Moriyama Y; Sakaguchi T
    Chem Pharm Bull (Tokyo); 1976 Jun; 24(6):1137-45. PubMed ID: 1021279
    [No Abstract]   [Full Text] [Related]  

  • 43. Determination of oxpentifylline and four metabolites in plasma and urine by automated capillary gas chromatography using nitrogen-selective detection.
    Burrows JL; Jolley KW
    J Chromatogr; 1985 Nov; 344():187-98. PubMed ID: 4086540
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Surprising effects of the sequential administration of pentoxifylline and low dose acetylsalicylic acid on thrombus formation.
    Seiffge D; Weithmann KU
    Thromb Res; 1987 Apr; 46(2):371-83. PubMed ID: 3603430
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Statistical evaluation of polygraphic investigations of pentoxifylline.
    Jovanović UJ
    J Int Med Res; 1976; 4(4):211-22. PubMed ID: 193745
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Potassium metabolism in renal failure (author's transl)].
    Sugino N
    Nihon Naika Gakkai Zasshi; 1977 Jun; 66(6):611-20. PubMed ID: 915358
    [No Abstract]   [Full Text] [Related]  

  • 47. Release of plasminogen activator by pentoxifylline and its major metabolite.
    Klöcking HP; Hoffmann A; Markwardt F
    Thromb Res; 1987 Jun; 46(5):747-50. PubMed ID: 3629547
    [No Abstract]   [Full Text] [Related]  

  • 48. Comparison of pentoxifylline pharmacokinetics between smokers and nonsmokers.
    Mauro VF; Mauro LS; Hageman JH
    J Clin Pharmacol; 1992 Nov; 32(11):1054-8. PubMed ID: 1474168
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High-performance liquid chromatographic analysis of pentoxifylline and 1-(5'-hydroxyhexyl)-3,7-dimethylxanthine in whole blood.
    Grasela DM; Rocci ML
    J Chromatogr; 1987 Aug; 419():368-74. PubMed ID: 3667793
    [No Abstract]   [Full Text] [Related]  

  • 50. Determination of 3,7-dimethyl-1-(5-oxohexyl)-xanthine (pentoxifylline) and its 3,7-dimethyl-1-(5-hydroxyhexyl)-xanthine metabolite in the plasma of patients with multiple diseases using high-performance liquid chromatography.
    Rieck W; Platt D
    J Chromatogr; 1984 Feb; 305(2):419-27. PubMed ID: 6707169
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Microbial models of mammalian metabolism: stereospecificity of ketone reduction with pentoxifylline.
    Davis PJ; Yang SK; Smith RV
    Xenobiotica; 1985 Dec; 15(12):1001-10. PubMed ID: 3911603
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gas chromatographic determination of pentoxifylline and its major metabolites in human breast milk.
    Bauza MT; Smith RV; Knutson DE; Witter FR
    J Chromatogr; 1984 Sep; 310(1):61-9. PubMed ID: 6501523
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Determination of 1-(3'-carboxypropyl)-3,7-dimethylxanthine and 1-(4'-carboxybutyl)-3,7-dimethylxanthine, two major metabolites of oxpentifylline, in urine by high-performance liquid chromatography.
    Bryce TA; Burrows JL; Jolley KW
    J Chromatogr; 1985 Nov; 344():397-402. PubMed ID: 4086565
    [No Abstract]   [Full Text] [Related]  

  • 54. Pharmacokinetics of metolazone in normal subjects and in patients with cardiac or renal failure.
    Tilstone WJ; Dargie H; Dargie EN; Morgan HG; Kennedy AC
    Clin Pharmacol Ther; 1974 Aug; 16(2):322-9. PubMed ID: 4853601
    [No Abstract]   [Full Text] [Related]  

  • 55. Microbial models of mammalian metabolism: microbial reduction and oxidation of pentoxifylline.
    Davis PJ; Yang SK; Smith RV
    Appl Environ Microbiol; 1984 Aug; 48(2):327-31. PubMed ID: 6486781
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Determination of oxpentifylline and three metabolites in plasma by automated capillary gas chromatography using nitrogen-selective detection.
    Burrows JL
    J Chromatogr; 1987 Dec; 423():139-46. PubMed ID: 3443643
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The renal excretion of methyldopa.
    Myhre E; Brodwall EK; Stenbaek O; Hansen T
    Scand J Clin Lab Invest; 1972 Apr; 29(2):201-4. PubMed ID: 5029324
    [No Abstract]   [Full Text] [Related]  

  • 58. Pharmacokinetics of diclofenac sodium (Voltaren) and metabolites in patients with impaired renal function.
    Stierlin H; Faigle JW; Colombi A
    Scand J Rheumatol Suppl; 1978; (22):30-5. PubMed ID: 356243
    [No Abstract]   [Full Text] [Related]  

  • 59. Pentoxifylline and aplastic anemia.
    Mass RD; Venook AP; Linker CA; Zipkin RE
    Ann Intern Med; 1987 Sep; 107(3):427-8. PubMed ID: 3619234
    [No Abstract]   [Full Text] [Related]  

  • 60. Letter: Penicillin dose and creatinine clearance.
    Pazin GJ
    Ann Intern Med; 1976 Jun; 84(6):754. PubMed ID: 937898
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.